miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, January 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 109 Dimensions

Readers on

mendeley: 37 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PROGNOSTIC RELEVANCE OF MIR-422A IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Application WO-2017207690-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR PREDICTING SENSITIVITY OF OSTEOSARCOMA PATIENT TO ANTICANCER AGENT

Application EP-2930248-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.